Summary

The stretch marks treatment market is witnessing robust growth worldwide, supported by rising consumer awareness around aesthetic skin care, increasing incidences of obesity and pregnancy-related skin changes, and a shift toward non-invasive cosmetic procedures. Valued at US$ 3.1 billion in 2025, the market is expected to expand at a CAGR of 6.13% and reach US$ 4.7 billion by the end of 2032.

Market Insights

Stretch marks—caused by skin stretching, hormonal changes, and weight fluctuations—are increasingly prompting individuals to seek medical or cosmetic interventions. As demand for aesthetic enhancement grows across various demographics, stretch mark treatment options such as topical creams, serums, and laser therapies are becoming more mainstream. Aesthetic and skincare industries are responding to this trend by offering effective and safer alternatives for stretch mark reduction.

Key Drivers

1. Surging Demand for Non-Invasive Treatments: Minimally invasive options like laser resurfacing and topical treatments are gaining traction among consumers due to reduced discomfort and downtime.

2. Technology-Led Advancements: Ablative and non-ablative laser technologies offer targeted treatment with improved outcomes, encouraging both practitioners and patients to choose advanced devices over traditional methods.

3. Obesity and Post-Pregnancy Changes: The global rise in obesity and postpartum stretch marks is increasing the number of people seeking skin correction therapies.

Business Opportunity

The stretch marks treatment market presents significant growth opportunities:

• R&D and Product Innovation: Brands are focusing on plant-based and dermatologist-recommended formulations with higher efficacy and consumer safety.

• Untapped Emerging Markets: Rapid urbanization and increasing disposable income in regions like South Asia, Latin America, and parts of Africa are expanding the potential customer base.

• Growing Male Consumer Segment: Men are increasingly adopting cosmetic treatments, further boosting the demand for unisex skincare solutions.

However, high treatment costs—especially for laser and professional procedures—remain a major constraint. Additionally, limited access to skilled professionals in certain regions and varying results based on skin type continue to challenge market penetration.

Regional Analysis

United States

The U.S. leads the North American stretch marks treatment market, accounting for a significant share due to the widespread acceptance of cosmetic procedures and a growing teenage and postpartum population. Increased use of chemical peels and laser therapies for skin rejuvenation is accelerating growth.

Germany

Germany represents a prominent market in Europe, driven by rising obesity rates and higher consumer spending capacity. A strong presence of cosmetic clinics and access to advanced skin treatments make Germany a preferred market for both service providers and product manufacturers.

China

In East Asia, China holds a leading position, fueled by rising beauty standards and a surge in cosmetic treatment demand. Social media influence and increased emphasis on flawless skin have led to widespread acceptance of non-invasive skin treatments, especially laser-based procedures.

Key Players

Market leaders are enhancing their product portfolios with innovative, clinically tested, and user-friendly offerings:

• Clarins revamped its Stretch Mark Control formula with a plant-based complex and new sustainable packaging.

• Weleda expanded its physical presence with a new facility to support growing product demand.

Other notable players include Palmer’s, Bio-Oil, Himalaya, Mederma, NEOSTRATA, Merz Pharma, Dermaclara, and Unilever. These companies continue to invest in R&D, marketing, and global distribution to strengthen their competitive position.

Segmentation Overview

By Treatment Type

• Topical Treatments: Gels, Creams, Oils, Serums

• Procedural Treatments: Ablative and Non-ablative Laser Resurfacing, Radiofrequency Therapy, Infrared Radiation, Chemical Peels, Dermabrasion

By Stretch Mark Type

• Striae atrophicans (Thinned Skin)

• Striae gravidarum (Post Pregnancy)

• Striae distensae (Stretched Skin)

• Striae rubrae (Red)

• Striae albae (White)

• Striae nigra (Black)

• Striae caerulea (Dark Blue)

By End User

• Hospitals

• Dermatology Clinics

• Aesthetic Clinics

• Wellness and Spa Centers

• Home Care Settings

By Region

• North America

• Latin America

• Europe

• South Asia

• East Asia

• Oceania

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Stretch Marks Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Stretch Marks Treatment Market Outlook, 2019-2032
3.1. Global Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Topical Medications
3.1.1.1.1. Gels
3.1.1.1.2. Creams
3.1.1.1.3. Oils/Serums
3.1.1.2. Procedural Treatments
3.1.1.2.1. Radiofrequency Therapy
3.1.1.2.2. Non-ablative Laser Fractional Resurfacing
3.1.1.2.3. Ablative Laser Resurfacing
3.1.1.2.4. Infrared Devices/Radiations
3.1.1.2.5. Dermabrasion
3.1.1.2.6. Chemical Peels
3.2. Global Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Striae atrophicans (Thinned Skin)
3.2.1.2. Striae gravidarum (Post Pregnancy)
3.2.1.3. Striae distensae (Stretched Skin)
3.2.1.4. striae rubrae (Red)
3.2.1.5. Striae albae (White)
3.2.1.6. Striae nigra (Black)
3.2.1.7. Striae caerulea (Dark Blue)
3.3. Global Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Dermatology Clinics
3.3.1.3. Aesthetic Clinics
3.3.1.4. Wellness and Spa Centers
3.3.1.5. Home Care Settings
3.4. Global Stretch Marks Treatment Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Stretch Marks Treatment Market Outlook, 2019-2032
4.1. North America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Topical Medications
4.1.1.1.1. Gels
4.1.1.1.2. Creams
4.1.1.1.3. Oils/Serums
4.1.1.2. Procedural Treatments
4.1.1.2.1. Radiofrequency Therapy
4.1.1.2.2. Non-ablative Laser Fractional Resurfacing
4.1.1.2.3. Ablative Laser Resurfacing
4.1.1.2.4. Infrared Devices/Radiations
4.1.1.2.5. Dermabrasion
4.1.1.2.6. Chemical Peels
4.2. North America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Striae atrophicans (Thinned Skin)
4.2.1.2. Striae gravidarum (Post Pregnancy)
4.2.1.3. Striae distensae (Stretched Skin)
4.2.1.4. striae rubrae (Red)
4.2.1.5. Striae albae (White)
4.2.1.6. Striae nigra (Black)
4.2.1.7. Striae caerulea (Dark Blue)
4.3. North America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Dermatology Clinics
4.3.1.3. Aesthetic Clinics
4.3.1.4. Wellness and Spa Centers
4.3.1.5. Home Care Settings
4.4. North America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. U.S. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
4.4.1.2. U.S. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
4.4.1.3. U.S. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
4.4.1.4. Canada Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
4.4.1.5. Canada Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
4.4.1.6. Canada Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Stretch Marks Treatment Market Outlook, 2019-2032
5.1. Europe Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Topical Medications
5.1.1.1.1. Gels
5.1.1.1.2. Creams
5.1.1.1.3. Oils/Serums
5.1.1.2. Procedural Treatments
5.1.1.2.1. Radiofrequency Therapy
5.1.1.2.2. Non-ablative Laser Fractional Resurfacing
5.1.1.2.3. Ablative Laser Resurfacing
5.1.1.2.4. Infrared Devices/Radiations
5.1.1.2.5. Dermabrasion
5.1.1.2.6. Chemical Peels
5.2. Europe Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Striae atrophicans (Thinned Skin)
5.2.1.2. Striae gravidarum (Post Pregnancy)
5.2.1.3. Striae distensae (Stretched Skin)
5.2.1.4. striae rubrae (Red)
5.2.1.5. Striae albae (White)
5.2.1.6. Striae nigra (Black)
5.2.1.7. Striae caerulea (Dark Blue)
5.3. Europe Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Dermatology Clinics
5.3.1.3. Aesthetic Clinics
5.3.1.4. Wellness and Spa Centers
5.3.1.5. Home Care Settings
5.4. Europe Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Germany Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.2. Germany Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.3. Germany Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.4. U.K. Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.5. U.K. Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.6. U.K. Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.7. France Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.8. France Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.9. France Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.10. Italy Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.11. Italy Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.12. Italy Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.13. Turkey Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.14. Turkey Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.15. Turkey Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.16. Russia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.17. Russia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.18. Russia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.1.19. Rest of Europe Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
5.4.1.20. Rest of Europe Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
5.4.1.21. Rest of Europe Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Stretch Marks Treatment Market Outlook, 2019-2032
6.1. Asia Pacific Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Topical Medications
6.1.1.1.1. Gels
6.1.1.1.2. Creams
6.1.1.1.3. Oils/Serums
6.1.1.2. Procedural Treatments
6.1.1.2.1. Radiofrequency Therapy
6.1.1.2.2. Non-ablative Laser Fractional Resurfacing
6.1.1.2.3. Ablative Laser Resurfacing
6.1.1.2.4. Infrared Devices/Radiations
6.1.1.2.5. Dermabrasion
6.1.1.2.6. Chemical Peels
6.2. Asia Pacific Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Striae atrophicans (Thinned Skin)
6.2.1.2. Striae gravidarum (Post Pregnancy)
6.2.1.3. Striae distensae (Stretched Skin)
6.2.1.4. striae rubrae (Red)
6.2.1.5. Striae albae (White)
6.2.1.6. Striae nigra (Black)
6.2.1.7. Striae caerulea (Dark Blue)
6.3. Asia Pacific Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Dermatology Clinics
6.3.1.3. Aesthetic Clinics
6.3.1.4. Wellness and Spa Centers
6.3.1.5. Home Care Settings
6.4. Asia Pacific Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. China Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.2. China Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.3. China Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.1.4. Japan Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.5. Japan Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.6. Japan Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.1.7. South Korea Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.8. South Korea Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.9. South Korea Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.1.10. India Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.11. India Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.12. India Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.1.13. Southeast Asia Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.14. Southeast Asia Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.15. Southeast Asia Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.1.16. Rest of Asia Pacific Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
6.4.1.17. Rest of Asia Pacific Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
6.4.1.18. Rest of Asia Pacific Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Stretch Marks Treatment Market Outlook, 2019-2032
7.1. Latin America Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Topical Medications
7.1.1.1.1. Gels
7.1.1.1.2. Creams
7.1.1.1.3. Oils/Serums
7.1.1.2. Procedural Treatments
7.1.1.2.1. Radiofrequency Therapy
7.1.1.2.2. Non-ablative Laser Fractional Resurfacing
7.1.1.2.3. Ablative Laser Resurfacing
7.1.1.2.4. Infrared Devices/Radiations
7.1.1.2.5. Dermabrasion
7.1.1.2.6. Chemical Peels
7.2. Latin America Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
7.2.1.1. Striae atrophicans (Thinned Skin)
7.2.1.2. Striae gravidarum (Post Pregnancy)
7.2.1.3. Striae distensae (Stretched Skin)
7.2.1.4. striae rubrae (Red)
7.2.1.5. Striae albae (White)
7.2.1.6. Striae nigra (Black)
7.2.1.7. Striae caerulea (Dark Blue)
7.3. Latin America Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Dermatology Clinics
7.3.1.3. Aesthetic Clinics
7.3.1.4. Wellness and Spa Centers
7.3.1.5. Home Care Settings
7.4. Latin America Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Brazil Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
7.4.1.2. Brazil Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
7.4.1.3. Brazil Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
7.4.1.4. Mexico Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
7.4.1.5. Mexico Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
7.4.1.6. Mexico Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
7.4.1.7. Argentina Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
7.4.1.8. Argentina Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
7.4.1.9. Argentina Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
7.4.1.10. Rest of Latin America Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
7.4.1.11. Rest of Latin America Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
7.4.1.12. Rest of Latin America Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Stretch Marks Treatment Market Outlook, 2019-2032
8.1. Middle East & Africa Stretch Marks Treatment Market Outlook, by Treatment, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Topical Medications
8.1.1.1.1. Gels
8.1.1.1.2. Creams
8.1.1.1.3. Oils/Serums
8.1.1.2. Procedural Treatments
8.1.1.2.1. Radiofrequency Therapy
8.1.1.2.2. Non-ablative Laser Fractional Resurfacing
8.1.1.2.3. Ablative Laser Resurfacing
8.1.1.2.4. Infrared Devices/Radiations
8.1.1.2.5. Dermabrasion
8.1.1.2.6. Chemical Peels
8.2. Middle East & Africa Stretch Marks Treatment Market Outlook, by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Striae atrophicans (Thinned Skin)
8.2.1.2. Striae gravidarum (Post Pregnancy)
8.2.1.3. Striae distensae (Stretched Skin)
8.2.1.4. striae rubrae (Red)
8.2.1.5. Striae albae (White)
8.2.1.6. Striae nigra (Black)
8.2.1.7. Striae caerulea (Dark Blue)
8.3. Middle East & Africa Stretch Marks Treatment Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Dermatology Clinics
8.3.1.3. Aesthetic Clinics
8.3.1.4. Wellness and Spa Centers
8.3.1.5. Home Care Settings
8.4. Middle East & Africa Stretch Marks Treatment Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. GCC Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
8.4.1.2. GCC Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.4.1.3. GCC Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
8.4.1.4. South Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
8.4.1.5. South Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.4.1.6. South Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
8.4.1.7. Egypt Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
8.4.1.8. Egypt Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.4.1.9. Egypt Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
8.4.1.10. Nigeria Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
8.4.1.11. Nigeria Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.4.1.12. Nigeria Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
8.4.1.13. Rest of Middle East & Africa Stretch Marks Treatment Market by Treatment, Value (US$ Bn), 2019-2032
8.4.1.14. Rest of Middle East & Africa Stretch Marks Treatment Market by Stretch Mark Type, Value (US$ Bn), 2019-2032
8.4.1.15. Rest of Middle East & Africa Stretch Marks Treatment Market by End User, Value (US$ Bn), 2019-2032
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Treatment vs Stretch Mark Type Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Weleda
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Clarins
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. basq NYC
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Body Merry
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Himalaya Global Holdings Ltd.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Stratpharma AG (Stratpharma Inc.)
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Browne Drug Co., Inc. (Palmer’s)
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Mederma (HRA Pharma)
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Givaudan SA
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Merz Pharma
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Unilever
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Bio-Oil (Union Swiss (Pty) Ltd)
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations